🇺🇸 FDA
Pipeline program

Leuprorelin SR

TAP III/98/032

Phase 3 small_molecule completed

Quick answer

Leuprorelin SR for Prostatic Neoplasms, Locally Advanced is a Phase 3 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Prostatic Neoplasms, Locally Advanced
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials